Posted by ABMN Staff on May 21st, 2024
Precigen (NASDAQ:PGEN – Get Free Report) was upgraded by investment analysts at StockNews.com to a “sell” rating in a report issued on Tuesday.
A number of other research firms have also commented on PGEN. JMP Securities...
More of this article »